DK0806206T3 - Vandige præparater indeholdende ciprofloxacin og tilknyttet anvendelse og fremgangsmåde deraf - Google Patents

Vandige præparater indeholdende ciprofloxacin og tilknyttet anvendelse og fremgangsmåde deraf

Info

Publication number
DK0806206T3
DK0806206T3 DK96924896T DK96924896T DK0806206T3 DK 0806206 T3 DK0806206 T3 DK 0806206T3 DK 96924896 T DK96924896 T DK 96924896T DK 96924896 T DK96924896 T DK 96924896T DK 0806206 T3 DK0806206 T3 DK 0806206T3
Authority
DK
Denmark
Prior art keywords
preparations containing
aqueous preparations
associated use
containing ciprofloxacin
ciprofloxacine
Prior art date
Application number
DK96924896T
Other languages
Danish (da)
English (en)
Inventor
Soler Pedro Canovas
Duarte Joaquin Delgadillo
Rueda Juan Moreno
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Application granted granted Critical
Publication of DK0806206T3 publication Critical patent/DK0806206T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK96924896T 1995-08-03 1996-07-26 Vandige præparater indeholdende ciprofloxacin og tilknyttet anvendelse og fremgangsmåde deraf DK0806206T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09501578A ES2106680B1 (es) 1995-08-03 1995-08-03 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
PCT/ES1996/000155 WO1997005880A1 (es) 1995-08-03 1996-07-26 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes

Publications (1)

Publication Number Publication Date
DK0806206T3 true DK0806206T3 (da) 2003-12-08

Family

ID=8291281

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96924896T DK0806206T3 (da) 1995-08-03 1996-07-26 Vandige præparater indeholdende ciprofloxacin og tilknyttet anvendelse og fremgangsmåde deraf

Country Status (12)

Country Link
US (1) US5786363A (de)
EP (1) EP0806206B1 (de)
JP (1) JP4081521B2 (de)
AT (1) ATE247962T1 (de)
AU (1) AU701697B2 (de)
CA (1) CA2200760C (de)
DE (1) DE69629664T2 (de)
DK (1) DK0806206T3 (de)
ES (2) ES2106680B1 (de)
PT (1) PT806206E (de)
RU (1) RU2165755C2 (de)
WO (1) WO1997005880A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
ES2160090B1 (es) * 2000-03-16 2002-07-01 Vita Invest Sa Composiciones acuosas de ciprofloxacino, contenidas en envases monodosis y su utilizacion.
US20030139382A1 (en) * 2001-09-21 2003-07-24 Alcon, Inc. Method of treating middle ear infections
MX2011000862A (es) * 2008-07-21 2011-03-15 Otonomy Inc Composiciones antimicrobianas de liberacion controlada y metodos para el tratamiento de trastornos oticos.
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
EP2366408B1 (de) * 2010-03-01 2012-07-18 Laboratorios SALVAT, S.A. Wässrige klare Lösungen aus Fluocinolon-Acetonid zur Behandlung von Ohrentzündungen
EP3512513A4 (de) 2016-09-16 2020-04-15 Otonomy, Inc. Gelformulierungen für das ohr zur behandlung von otitis externa
CN112986468B (zh) * 2019-12-13 2024-05-03 武汉九州钰民医药科技有限公司 检测盐酸环丙沙星片中氯代环丙沙星的分析方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5531042A (en) * 1978-08-25 1980-03-05 Dainippon Pharmaceut Co Ltd 1,8-naphthylidine derivative and its salt
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3248505A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(4- (oxoalkyl)-1-piperazinyl/-3-chinolincarbonsaeuren und ihre derivate, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3632222A1 (de) * 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren
DE69224071T2 (de) * 1991-09-17 1998-05-07 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
JPH11500740A (ja) 1999-01-19
EP0806206A1 (de) 1997-11-12
RU2165755C2 (ru) 2001-04-27
ES2106680B1 (es) 1998-07-01
JP4081521B2 (ja) 2008-04-30
EP0806206B1 (de) 2003-08-27
AU701697B2 (en) 1999-02-04
ES2106680A1 (es) 1997-11-01
US5786363A (en) 1998-07-28
CA2200760C (en) 2007-09-11
PT806206E (pt) 2004-01-30
AU6520196A (en) 1997-03-05
DE69629664D1 (de) 2003-10-02
DE69629664T2 (de) 2004-06-24
ES2205048T3 (es) 2004-05-01
ATE247962T1 (de) 2003-09-15
CA2200760A1 (en) 1997-02-20
WO1997005880A1 (es) 1997-02-20

Similar Documents

Publication Publication Date Title
DK1200418T3 (da) Nematodicide trifluorbutener
ATE163418T1 (de) Risperidon pamoate
MX9206008A (es) Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida.
YU49354B (sh) Oralne tečne formulacije alendronata
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
AR002932A1 (es) Solucion acuosa de interferon
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
DK0579681T3 (da) Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse
NO971903L (no) Krystallisering av levobupivacain og analoger derav
DK0806206T3 (da) Vandige præparater indeholdende ciprofloxacin og tilknyttet anvendelse og fremgangsmåde deraf
DK0589995T3 (da) Hidtil ukendte polypeptider og deres anvendelse
DE69423402D1 (de) Stabile, pharmazeutische Zusammensetzungen die hybrid alpha-Interferon enthalten
CO4340718A1 (es) Granulos fungicidas dispersables en agua que contienen n-piridiltoluidina
ES2146606T3 (es) Metodo para limpiar alfombras.
ES2157221T3 (es) Composiciones metaloporfirinicas.
UY27373A1 (es) Formulaciones de interferón beta-humano
BG103306A (en) Liquid allendronate compositions
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
NO970350D0 (no) Forbindelser anvendelige som anti-formeringsmidler og GARFT-inhibitorer
DE69215511D1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
DE69706206D1 (de) Von Neurokininen abgeleitete Pseudopeptide, Verfahren für ihre Herstellung und sie enthaltende pharmazeutische Zubereitungen
ATE103606T1 (de) Verfahren zur herstellung von sulfinylpristinamycin iib.
IT8983421A0 (it) Sistema di giunzione particolarmente idoneo per l'assemblaggio di tavoli.
NO974687D0 (no) Kondenserte <beta>-carboliner